Affinity Asset Advisors, LLC

Position in OBIO — Orchestra BioMed Holdings, Inc.

CIK 1773195 NEW YORK, NY

Position in OBIO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$144,121

-$1,566,716 QoQ

Shares Held

33,400

-91.7% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#36

of 77 holders

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. OBIO ranks #84 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	3,750,000	$132,712,500
2	APGE	Apogee Therapeutics, Inc.	987,000	$131,004,510
3	SYRE	Spyre Therapeutics, Inc.	1,279,134	$113,561,516
4	XENE	Xenon Pharmaceuticals Inc.	1,595,000	$96,274,200
5	ERAS	Erasca, Inc.	5,250,000	$96,180,000
6	INSM	INSMED Inc	650,000	$69,303,000
7	PRAX	Praxis Precision Medicines, Inc.	185,000	$61,936,150
8	ORKA	Oruka Therapeutics, Inc.	590,000	$56,150,300

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$144,121	33,400	-91.7%	Shares	Sole	2026-08-13
2026-03-31	$1,710,837	402,550	-29.7%	Shares	Sole	2026-05-14
2025-12-31	$2,377,136	572,804	-21.2%	Shares	Sole	2026-02-13
2025-09-30	$1,803,634	727,272	—	Shares	Sole	2025-11-13
2022-03-31 HSAQ	—	300,000	0.0%	Shares	Sole	2022-05-13
2021-12-31 HSAQ	—	300,000	0.0%	Shares	Sole	2022-02-11
2021-09-30 HSAQ	—	300,000	0.0%	Shares	Sole	2021-11-12
2021-06-30 HSAQ	—	300,000	+33.3%	Shares	Sole	2021-08-13
2021-03-31 HSAQ	—	225,000	+12.5%	Shares	Sole	2021-05-14
2020-12-31 HSAQ	—	200,000	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.